Novavax Inc. NVAX
$9.51
▼ -1.66% 24H
About
Novavax Inc. is a biotechnology company specializing in the discovery, development, and commercialization of recombinant vaccines to address serious infectious diseases. The company focuses on using a proprietary recombinant nanoparticle technology platform combined with advanced adjuvants to generate robust immune res…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees749
TickerNVAX
Statistics
Market Cap$1.56B
Revenue (TTM)$1.12B
Net Income$440.3M
Net Margin39.2%
EPS$2.58
P/E3.63
P/S2.49
P/B-10.18
EV/EBITDA16.62
ROE-344.7%
Dividend Yield—
Price$9.51
Data: Twelve Data · Revenue = mcap / P/S